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In the TLR4 signaling pathways, we previously characterized
a signal regulator, LRRFIP2, thatmodulates the time course-de-
pendent changes inNF-B activity through its dynamic interac-
tion with the TLR adaptor protein, MyD88. However, little is
known about the driving force behind the LPS-inducible
dynamics between LRRFIP2 and MyD88. We have therefore
designed amultiplex label-free quantitative proteomicsmethod
to investigate dynamic changes of LRRFIP2 phosphorylation
upon LPS stimulation. Given our observation that LRRFIP2
binds toMyD88 through its serine-rich domain inwhichmost of
serine residues have the propensity to be phosphorylated, we
used collision-activated dissociation- and electron transfer dis-
sociation-basedmethods in a complementarymanner to unam-
biguously localize phosphorylation sites in the peptides consti-
tuting the serine-rich domain. Among 23 phosphorylation sites
identified and first quantified by the label-free approach and
then verified by the AACT/SILAC (amino acid-coded tagging/
stable isotope labeling in cell culture)-based quantitationmethod,
phosphorylation at serine 202 showed a significant LPS-induced
dynamic change during the full-course cellular response to LPS
stimulation. The substitution of serine 202 with nonphosphory-
lated residues by site-directedmutagenesis resulted in aweakened
LRRFIP2-MyD88 interaction and a concurrently reduced activity
in downstream NF-B. Taking these results together, phosphory-
lation at serine 202 was found to regulate the dynamics of the
LRRFIP2-MyD88 interaction, which in turn modulated the
strength and duration of TLR4 signaling. Strategically, we have
demonstrated the importance of precise identification of the bio-
logically relevant phosphorylation site(s) using comprehensive
mass spectrometry-based quantitative proteomics approaches in
guiding downstream biological characterization experiments,
which could otherwise be both time- and cost-consuming for a
large number of phosphorylation possibilities.
As the first line of defense, toll-like receptors (TLRs)2 can
sense diverse pathogenic products that activate the innate
immune/inflammatory response of the host cells (1–3). TLR4
specifically recognizes lipopolysaccharide (LPS), which is a
major component of the Gram-negative bacterial cell wall
(1–3). Through mechanisms that have yet to be explored,
emerging evidence suggests that LPS-triggered TLR4 signaling
is tightly modulated by specific intracellular protein-protein
interaction networks or interactomes (1). As an overview of
TLR4-mediated signaling (4), upon LPS stimulation, MyD88,
the common intracellular adaptor protein located immediately
downstream of most TLR molecules (5), can recruit specific
intracellular proteins along the MyD88-IRAK-TRAF6-IB-
NFB signal relay to eventually regulate the activity of down-
stream transcription factors such as NF-B (6–8). Using our
“dual tagging” quantitative proteomic method for signaling
complex analysis (9), we have demonstrated that novel signal-
ing proteins can be systematically identified from LPS-stimu-
lated living macrophages (9, 10).
A class of proteins containing a leucine-rich repeat (LRR)
motif has recently been found to play the central role in recog-
nition of diverse pathogen-associated molecules in host innate
defense in plants and animals (11). Among our identified
MyD88-interacting proteins, there were two LRR-containing
proteins (or Fliih-interacting proteins): leucine-rich repeat Fli-
I-interacting protein 2 (LRRFIP2) and Fli-I leucine-rich repeat-
associated protein 1 (Flap-1). The LRR-containing protein,
flightless I homologue (Fliih), was first characterized as a nega-
tivemediator ofNF-B activity (9, 10), whereas LRRFIP2 acts as
a positive regulator for activating NF-B during the early host
response to LPS stimulation (12). Further, through the com-
bined biological characterization and real-time quantitative
measurement of protein interactions, we have shown that,
depending upon the length of host exposure to a TLR agonist,
multiple proteins, including LRRFIP2, Fliih, andMyD88, inter-
act in a timely and orderly manner during the full course of
TLR-mediated signal transduction (12). However, the molecu-
lar mechanism remains obscure regarding how LPS-inducible
temporal interactions among these signaling proteins are reg-
ulated for control of the duration and strength of TLR4
signaling.
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It is estimated that 20% of the human genome encodes for
the proteins involved in signal transduction (13, 14), where
dynamic phosphorylation is known to play critical roles
through regulating specific protein-protein interactions (15–
17). Given that LRRFIP2 contains a serine-rich domain that has
a high propensity to be phosphorylated and has also been found
to be involved directly in LRRFIP2-MyD88 interaction (12), we
reasoned that specific phosphorylation(s) may show dynamic
changes in the MyD88-interacting domain of LRRFIP2 in an
LPS-inducible manner to regulate the temporal interactions
between these two proteins.
Emerging mass spectrometry (MS)-based techniques can
quantify phosphorylation changes in response to cellular per-
turbations that impinge upon particular biological systems
(18).We previously introduced a quantitative proteomics strat-
egy of amino acid-coded tagging (AACT) (19, 20), or SILAC as
named by another group (21), and have used it to identify the
ionizing radiation-induced phosphorylation of serine 139 of a
histone protein, H2AX (22). However, the quantitative capacity
of AACT-based approaches is restricted by its cell culture step
and maximum 3-plex design in a single experimental run (23).
Without the need for additional chemical reactions or cell
culture, emerging MS-based technology for label-free quanti-
tation has no bearing on the number of experimental samples
(i.e. a label-free approach in principal can capture an infinite
number of data points for a multiplex comparative analysis).
Currently available software tools for label-free quantitation
methodologies measure either spectral counts or the peak area
of a given peptide (24). The relative quantitation is achieved by
making comparisons of either peak area or spectral counts
across multiple mass spectra. At present, label-free quantita-
tion experiments require a high degree of chromatographic
reproducibility because data alignment is usually a prerequisite.
In addition, sample preparation protocols, data normalization,
and statistical validation are required for accurate and precise
quantitation. However, label-free technology for quantifying
phosphorylation changes can be a cost- and time-effective
methodology when large sample sets are involved in any time
course study.
In addition to the need for multiplex and precise quantita-
tion, unambiguous identification of site-specific phosphoryla-
tion becomes very critical for guiding andminimizing the time-
and cost-consuming concurrent experiments for functional
characterization of large numbers of phosphorylation sites.
Most often, proteinmodifications have been determined either
by identification or by localizing the site of modification by
MS/MS of proteolytic peptides (25–29). Ion trap-based mass
spectrometers such as the hybrid LTQ Orbitrap have enabled
the structural interrogation of the phosphoproteome (30). The
facile loss of a structurally uninformative phosphoric acid in ion
trap collision-activated/-induced dissociation (CAD/CID)-
MS/MS is a major impediment for peptide sequence analysis.
Data-dependent, phosphospecific CAD-MS3 is an efficient
strategy for obtaining the spectra of labile phosphopeptides
(31). The concurrent activation of a phosphopeptide and its
neutral loss product ions via a phosphorylation-dependent
pseudo-MS3 has assisted in the localization of phosphorylation
sites (32). However, a recent study has shown that incorrect
phosphorylation site assignment is possible for peptides con-
taining multiple serine or threonine residues because of a gas
phase rearrangement of the phosphate group during in-trap
CAD (33). In this regard, electron-based dissociation methods
such as electron capture dissociation (ECD) and electron trans-
fer dissociation (ETD) have been developed for the accurate
localization of phosphorylation sites due to the preservation of
labile bonds while efficiently cleaving theN–C bonds of a pep-
tide (34–37). The ETD technology has been implemented for
peptides separated on a chromatographic time scale in stand-
alone ion traps, high resolution and accurate mass hybrid
instruments such as the ion trap-Orbitrap (38). The emergence
of bioinformatics tools to analyze data from these technology
developments has further improved the precision of large scale
phosphoproteomics analysis (39, 40).
Here we demonstrate a comprehensive workflow that
includes multiplex targeted label-free quantitation and com-
plementary ion dissociation methods for both accurate quanti-
tation and precise identification of those residues of LRRFIP2
showing the LPS-inducible and time course-dependent phos-
phorylation changes. Using various biological approaches, we
have elucidated the possible functional role of novel phosphor-
ylation site(s) precisely identified by quantitative MS-based
approaches. Our discovery-based strategy is fully illustrated by
the precision with which the phosphorylation sites have been
localized; the biological significance of the quantitative thresh-
old and the dynamic phosphorylation changes are closely cor-
related with the functional role of LRRFIP2 in TLR4 signaling
(i.e. the site-specific phosphorylation changes or the lack
thereof correlateswith the LPS-induced changes or lack thereof
in the key components of the TLR4-mediated signal transduc-
tion involved in LRRFIP2-MyD88 interaction and downstream
NF-B activation). The results of our biological experiments
further illustrate the accuracy of our discovery-based mass
spectrometry workflow.
EXPERIMENTAL PROCEDURES
Reagents andMaterials, Cell Culture/Transfection, Immuno-
precipitation, and AACT Labeling—LPS (from Escherichia coli
0111:B4, Ultra-pure) were purchased from InvivoGen. Anti-
FLAG (M2) and anti-HA were from Sigma-Aldrich. The
HEK293T cell line stably expressing TLR4 (both labeled and
unlabeled) was cultured as described previously (9, 10).
HEK293T/TLR4/MD-2 cells were transfected with plasmid
expressing FLAG-tagged LRFFIP2 using Lipofectamine 2000
(Invitrogen) as described previously (12). At 24 h post-transfec-
tion, the cells were stimulated with 1 ng/l LPS-B4 and col-
lected at different time points. With a higher transfection
efficiency, the RAW cell transfections were done by using
jetPRIME transfection reagent from Polyplus (New York, NY)
according to manufacturer’s directions. The whole-cell lysates
for each time point, containing 6–10 million cells, were pre-
treated with mouse IgG and protein G-agarose. FLAG-tagged
LRRFIP2 was immunoprecipitated from supernatants with
mouse monoclonal anti-FLAG M2 antibody-agarose (Sigma-
Aldrich). Immunoprecipitates were eluted with 1 SDS gel
loading buffer and separated on NuPAGE 4–12% bis-Tris gel
(Invitrogen). In-gel digestion was performed on the protein
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bands of interest (41). For multiplex label-free experiments,
using anti-FLAGantibody, the same immunoprecipitation pro-
cedure as described above was performed to isolate the “snap-
shot” FLAG-tagged LRRFIP2 from the TLR4 stable HEK cells
collected at different time points including 0, 1, 5, 10, 20, and 60
min following LPS stimulation.
AACT/SILAC labeling of the 293T-TLR4 cells was carried
out based on the protocol described previously (9, 10). In this
case, the nonstimulated cells were labeledwith Leu-d3, whereas
the unlabeled cells were stimulated for 10minwith LPS. FLAG-
taggedLRRFIP2was immunoprecipitated from the cell lysate of
each labeled or unlabeled cells before mixing at a 1:1 ratio.
Mass Spectrometry Analysis—Samples were desalted using
PepClean C18 spin columns (Pierce) according to manufactur-
er’s directions and resuspended in an aqueous solution of 0.1%
formic acid. Analysis of most samples was performed via
reversed phase LC-MS/MS using a two-dimensional nanoLC-
Ultra system (Eksigent Technologies, Dublin, CA) coupled to
an LTQ Orbitrap XL system with ETD (Thermo Scientific).
The Eksigent system was configured to trap and elute peptides
in the one-dimensional mode of operation via a sandwiched
injection of 250 fmol of sample. The trapping was performed
on a 3-cm long, 100-m inner diameter C18 column, and elu-
tion was performed on a 15-cm long, 75-m inner diameter,
5-m, 300 Å particle (ProteoPep II integraFrit C18 column,
New Objective Inc., Woburn, MA). Analytical separation of all
the tryptic peptides was achieved with a linear gradient of
2–40% buffer B over either 70 or 120 min at a 200 nl/min flow
rate, where buffer A is an aqueous solution of 0.1% formic acid
and buffer B is a solution of acetonitrile in 0.1% formic acid.
Mass spectrometric data acquisition was performed in a
data-dependent manner on a hybrid LTQ Orbitrap mass spec-
trometer. A full-scan mass analysis on an Orbitrap (externally
calibrated to a mass accuracy of 1 ppm and a user-defined
resolution of 30,000) was followed by intensity-dependent
MS/MS of the top six most abundant peptide ions in the linear
ion trap. CAD-MS/MS and ETD-MS/MSwere used as comple-
mentary methods to dissociate peptides. All CAD-MS/MS
spectrawere obtained for peptide ions thatwere subjected to 30
ms resonance activation at normalized collision energy of 35 eV
in the presence of helium bath gas atoms at a pressure of 1
mtorr. All ETD-MS/MS spectra were obtained by performing
an ion/ion reaction between peptide cations and fluoranthene
anions mutually stored for 100 ms within a linear ion trap. The
MS/MS acquisition of a precursor m/z was repeated for a 30-s
duration and subsequently excluded for 60 s. Monoisotopic
precursor ion selection and charge state screening were
enabled to trigger data-dependentMS/MS scans. A few neutral
H3PO4 loss-dependent CAD-MS3 experiments and targeted
peptide CAD-MS/MS experiments were also performed.
The AACT samples were identified by a MALDI-TOF/TOF
4700 proteomics analyzer (Applied Biosystems, Framingham,
MA).Mass spectrawere obtained using a 200-HzNd:YAG laser
operating at 355 nm. External calibrationwas performed before
each run using a myoglobin digest. CAD-MS/MS was per-
formed with a collision voltage of 1 kV with air as the collision
gas. Spectra were accumulated for 2000–3000 consecutive
laser shots. A mixture of 2,5-dihydroxybenzoic acid (30
mgml1, 0.5 l) and phosphoric acid (1%, 0.5 l) was used as
the MALDI matrix. Mass spectra were processed, and peptide
identification was performed using Mascot (Matrix Science
Inc.) and Sequest (Thermo Fisher Scientific) search algorithms
against a human-IPI (international protein index) database
(version 3.63). Peptides were confidently identified using a tar-
get-decoy approach with a false discovery rate of 1%. A precur-
sor ion mass tolerance of 100 ppm and a product ion mass
tolerance 0.5 Da were used during the search with a maximum
of two missed trypsin cleavages. Variable modifications
included methionine oxidation and phosphorylation at serine,
threonine, and tyrosine residues. A few searches were also car-
ried out using C-terminal sodiation and deamidation at aspar-
agine residues. The Ascore algorithm was used to confidently
localize the phosphorylation site on the peptide.
Peptide Quantitation—Label-free quantitation was based on
relative peak areas of the identified phosphopeptides and cor-
responding nonphosphopeptide counterpart. The raw peaks
were processed, and extracted ion chromatograms (XIC) were
generated from the full-scan MS using Xcalibur software. Pep-
tide peaks of interests were normalized by internal standard
peak areas of a tryptic peptide derived from a digest of bee
venom mellitin (Sigma-Aldrich), and introduced into each
sample during LC-MS analysis. The variations in electrospray
ionization (ESI) response were normalized by the response of
the dioctyl phthalate ions (m/z 391.28) used as a reference
standard. The integration of each analyte data point was per-
formed using theGenesis algorithm (ThermoFisher Scientific).
The normalization of each analyte data point with a corre-
sponding data point of the reference standard was performed
using a PerlScript that was written in-house. All deviations in
retention timewere corrected by peak alignment. The accuracy
of the peak area ratioswas validated by acquiringmultiple chro-
matographic runs at 90 and 120 min with the linear gradients
described above. Label-free quantitation of phosphorylation is
based on site occupancy and requires a summation of the peak
areas of all phosphopeptides and nonphosphopeptide counter-
parts comprising the putative phosphorylation site. The per-
centage of the normalized phosphorylation level for a given site
is shown in Equation 1, where M is the peptide sequence of
interest and n is the charge state. It is noteworthy that % phos-
phorylation does not reflect the “true” percentage of phosphor-
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(Eq. 1)
The following degenerate forms of peptideM include the semi-
tryptic peptides, methionine oxidation, and asparagine deami-
dation. The peak area is summed across all degenerate forms,
charge states, and adduct ions of a peptide. The quantitation
methodologywas applied to LC-MS data collected for each LPS
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stimulation time point. Multiple technical and biological repli-
cates were analyzed for statistical validation of results.
AACT-based quantitation was performed on Leu-d3/Leu-d0
doublet peaks andArg-0/Lys-0, Arg-6/Lys-4, andArg-10/Lys-6
dual tagged triplet peaks, respectively. Each peakwas processed
using standard peak filtering criteria, searched using Mascot
according to the method described above, and quantified using
Mascot distiller inscribed with the appropriate quantitation
method.
Site-directed Mutagenesis—Site-directed mutagenesis of
full-length FLAG-LRRFIP2 in pCS2 vector was performed
using the QuikChange site-directed mutagenesis kit (Strat-
agene, La Jolla, CA). To change the selected serines to alanines,
we used the following synthetic oligonucleotides: CTG AGA
AGT GCC GCT CTG GCA TCA TTG (Ser-2023 Ala), CTG
GTC TGC TGA GAA GTG CCG AGC TGG CAT CAT TGT
ACAATGG (Ser-2023Glu), and ATTTGCAGTAGGAGC
GGC CCT GTC ACT (Ser-1903 Ala). We used the oligonu-
cleotides for Ser-1903Ala and the plasmid LRRFIP2 S202A
as the template to make the double mutant S190A,S202A
(Ser-1903 Ala and Ser-2023 Ala).
LRRFIP2 Knockdown, RT-PCR, and Expression of LRRFIP2
Constructs in RAW264.7 Cells—RAW264.7 cells were trans-
fected with an shRNA construct (12) targeting the endogenous
mouseLRRFIP2 gene or scrambled shRNAas a negative control
using jetPRIME transfection reagent. The human wild-type
and mutant LRRFIP2 constructs were prepared using the
QuikChange (Agilent, Santa Clara, CA) site-directed mutagen-
esis kit in the shRNA binding region, resulting in nucleotide
changes but preserving the amino acid sequence. Thus,with the
shRNA construct, we could achieve knockdown of endogenous
mouse LRRFIP2 but not the transfected human LRRFIP2
constructs.
Total RNA was prepared from RAW264.7 cells cultured in
24-well plates using the GeneJet RNA purification kit (Fermen-
tas Inc., Glen Burnie, MD), and first-strand synthesis was done
with MMLV reverser transcriptase (Promega, Madison, WI).
Quantitative real-time polymerase chain reaction was per-
formed by using real-time SYBR Green reagent (Fermentas
Inc.) with gene-specific primers on the 7300 Real-time PCR
System (Stratagene). Measurements were done in triplicate.
Equal numbers of RAW264.7 cells were transfected with
empty vector, wild-type LRRFIP2, or the LRRFIP2mutant con-
structs. As the transfection efficiency of RAW cells is much
lower than the HEK293T cells, we detected only very weak
LRRFIP2 expression in whole-cell lysates, which were not
reproduced as an image. Thus, to verify the exogenous expres-
sion of human LRRFIP2 or LRRFIP2 mutants in the mouse
LRRFIP2 knockdown cells, we enriched the expressed LRRFIP2
or LRRFIP2 mutants through immunoprecipitation by apply-
ing equal amounts of FLAG M2-agarose (Sigma-Aldrich) to
equal amounts of each transfected cells. The immunoprecipi-
tates were separated on SDS-PAGE and transferred by electro-
blotting onto nitrocellulose membrane. FLAG-tagged human
LRRFIP2 were then detected by using anti-FLAG antibody.
Luciferase Assay—RAW264.7 cells were seeded on 24-well
plates 1 day before transfection in 500 l of growth medium
without antibiotics such that they were 60–70% confluent at
the time of transfection. Cells were transfected with 100 ng of
pGL2-ELAMpromoter luciferase transgene and 290 ng ofwild-
type LRRFIP2, the mutant, or empty vector plasmid, 90 ng of
LRRFIP2 shRNA, and 20 ng of pRL-TK as the internal control.
An internal control (pRL-TK) that expresses Renilla luciferase
was co-transfected to normalize the transfection efficiency and
sample handling. The cells were exposed to 0.5 g/ml LPS for
6 h at 24 h after transfection, and the activities of the two dif-
ferent luciferases were assayed with their respective substrates
with a Dual-Luciferase assay kit (Promega, Madison, WI). The
data were normalized for NF-B activity, i.e. the values
obtained from the division of the firefly luciferase activity by the
Renilla luciferase activity. The results obtained from triplicate
runs of each sample were then averaged. The data presented
are the mean  S.E. (n 	 3). Similar results were obtained in
three independent experiments.
Co-immunoprecipitation and Immunoblotting—293T cells
stably expressing TLR4-MD2 (stable cells) were transiently
transfected with HA-MyD88 and either wild-type FLAG-LR-
RFIP2 or FLAG-LRRFIP2 mutants such as S202A, S202E, etc.,
respectively. The cells were treated with 1 mg/ml LPS and har-
vested at different time points after the LPS stimulation. The
cells were lysed with lysis buffer (1%Nonidet P-40, 50mMTris-
HCl (pH 7.6), 150 mM NaCl, 2 mM EDTA, 1 mM sodium vana-
date, 5 g/ml leupeptin, 5 g/ml aprotinin, and 1 mM PMSF),
and precleared by centrifugation at 16,000  g for 15 min.
About 1 mg of total protein was incubated with or without the
indicated antibodies for 1 h at 4 °C and subsequently with pro-
tein A- or protein G-agarose beads overnight at 4 °C on a rotat-
ing platform. After centrifugation, beads were washed five
times with lysis buffer. Bound proteins were eluted with the
SDS sample buffer.
The immunoprecipitation and whole-cell lysate samples
were separated on a 3–8% Tris acetate gel (Invitrogen) and
transferred to nitrocellulose membrane, and the membrane
was then blocked with 5% milk in 1 Tris-buffered saline with
0.01% Tween 20 (1 TBS-T). The membrane was then incu-
bated with the appropriate primary antibodies for 4–6 h,
washed five times with 1 TBS-T, and then incubated with the
appropriate HRP-linked secondary antibodies for 1 h. The
membrane was again washed five times with 1 TBS-T, incu-
bated with chemiluminescent substrate for 1 min, and then
exposed to film and visualized using the ECL Plus detection
system (GE Healthcare).
RESULTS AND DISCUSSION
MS-based Label-free Quantitation—Using anti-FLAG anti-
body, we took a snapshot of FLAG-tagged LRRFIP2 by immu-
noprecipitating it from TLR4 stable HEK cells at 0, 2, 5, 10, 20,
and 60min after LPS stimulation. To compare the ratio of phos-
phorylated to nonphosphorylated peptide ions, tryptic digests
of LRRFIP2 isolated at each time point were separated by high-
resolution liquid chromatography, and all LRRFIP2-specific
phosphopeptides were analyzed by mass spectrometry. Full-
scan MS was performed on the accurate mass, high-resolution
Orbitrap mass analyzer for precise mass measurement of pep-
tide precursor ions and XIC. Quantitation was performed on
the XIC corresponding to the LC elution profile of the peptide
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of interest. Quantitation of LPS-induced changes for each
phosphopeptide and its nonphosphorylated counterpart was
carried out by aligning the retention times of the XIC profiles,
verifying the peptide identity, and unambiguously identifying
sites of phosphorylation based on the MS/MS spectrum.
Fig. 1 illustrates the complementary nature of the intensity-
dependent, targeted label-free, and single-reaction monitoring
(SRM) approaches used for quantitation of phosphopeptides.
The intensity-dependent MS/MS approach uses the full-MS
spectrum ion count for a peptide of interest to derive the chro-
matographic peak profile of the eluting peptide (Fig. 1A). How-
ever, the number of data points obtained in MS/MS was insuf-
ficient (7 for a 30-s peak width) to reconstruct the elution
profile for quantitation purposes. The targeted approach relies
on confident identification of phosphopeptides and corre-
sponding nonphosphopeptides, which are subsequently
mapped to the amino acid sequence of the intact protein (Fig.
1B). The mapping accounts for phosphopeptides with overlap-
ping sequences, other modifications, and adducts that consti-
tute a phosphorylation site. Most often, intensity/data-depen-
dent acquisitionmethods do not triggerMS/MS fragmentation
for every charge state, adduct, or modification and, hence, do
not enable the identification of every peptide species. To cir-
cumvent this issue, we combined anMS3 approach (see supple-
mental Fig. 1S) to identify phosphopeptides with targeted
MS/MS experiments using MS/MS spectrum ion counts to
reconstruct the elution profile for quantitation. The SRM
approach uses specific precursor-product ion transitions from
a MS/MS spectrum to reconstruct the elution profile of the
peptide of interest for quantitation (Fig. 1C). SRM experiments
performed on an Orbitrap mass spectrometer are analogous to
SRM experiments conducted on a triple quadrupole instru-
ment (42). The SRM experiment itself can be carried out in the
Fourier transform/ion trap (FT/IT) mode in which precursor
detection is based on Orbitrap (FT) mass measurement fol-
lowed by dissociation and product mass analysis in the linear
IT. For greater specificity, SRM data can be collected in the
FT/FT mode, in which both the initial precursor and ensuing
dissociation products are detected in the Orbitrap (FT).
Although the targeted SRM approach improves the specificity,
it does so at the cost of sensitivity, as evidenced by a reduction in
the ion count. To our knowledge, this is the first report of both
qualitative and quantitative peptide information obtained from
data-dependent MS/MS in conjunction with Orbitrap SRM
performed on a single instrument.
Using this array of complementary techniques, we identified
23 specific phosphorylation sites among a total of 34 LRRFIP2
phosphopeptides. In addition, we measured and quantified
LPS-induced temporal changes in 11LRRFIP2phosphorylation
sites. Here, we present quantitation data for selected LRRFIP2
FIGURE 1. Label-free quantitation of a phosphopeptide and corresponding nonphosphopeptide counterpart in a single LC-MS/MS run. A, XIC of
precursor ions derived from data-dependent analysis (DDA)-MS/MS. B, XIC of product ions derived from a targeted CAD-MS/MS. C, reconstructed SRM profile
using specific precursor-product ion pairs of phosphopeptide P. D, CAD-MS/MS of the corresponding phosphopeptide P.
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peptides (SASLASLYNGGLYNPYGR, RGSGSDTSSLIDPDT-
SLSELR, SDRASPATANGGLR, and ASPATANGGLR) to
illustrate the utility of label-free approaches for determining
statistically significant changes in phosphorylation upon LPS
stimulation. The biological function associated with each of the
newly identified phosphorylation sites is under investigation
and will be reported elsewhere.
Comprehensive Label-free Quantitation of LPS-induced
Dynamics of Multiple LRRFIP2 Phosphopeptides—Fig. 2 shows
theXICprofiles of the SASLASLYNGGLYNPYGRpeptide spe-
cies observed in a single LC-MS run. Both phosphorylated and
nonphosphorylated SASLASLYNGGLYNPYGR peptide sub-
populations are present in a given sample. In addition,metal ion
adducts (e.g. from sodium), shifts in charge state distribution,
and modifications (e.g. deamidation of asparagine residues)
could exist within each subpopulation and contribute to the
total ion signal. From the standpoint of label-free quantitation
methods based on the consideration of peak area, all of these
subpopulations must be taken into account to avoid quantita-
tive inaccuracies due to sample-to-sample variability.
Degenerate charge states and adducts are a consequence of
the electrospray ionization process, whereas deamidation
is an experimental artifact introduced during sample handling.
The mass and charge degeneracy introduced for the
SASLASLYNGGLYNPYGR peptide in our experiments was
mainly due to 3 and 2 charge states, sodium adduction, and
deamidation of asparagine. The mass difference between
charge states and sodium adduct peaks is typically large enough
to distinguish the peak area of each component based on the
XIC. However, deamidation of asparagine to isoaspartic acid
results in amass shift of 0.987Da for an ion of 1 charge, 0.4Da
for a 2 ion, and 0.3 Da for a 3 ion. The isotope clusters of the
deamidated and nondeamidated multiply charged peptides
cannot be chromatographically resolved and are therefore irrel-
evant for use in peak area calculations based on XICs. Because
deamidation of the SASLASLYNGGLYNPYGR peptide has no
biological relevance, peak areas corresponding to both the
deamidated and nondeamidated forms were simply summed in
our calculations.
In the case of some LRRFIP2 peptides sharing common
sequences, such as SDRASPTANGLLR and ASPATANGGLR,
in which the longer peptide results from a single missed tryptic
cleavage (underlined in bold), the phosphorylation pattern of
each peptidemay be similar or different andmutually exclusive.
The quantitative approach taken to determine the phosphory-
lation state of a peptide depends on the localization of the phos-
phorylation site; this will be described in greater detail below.
For example, if the identified phosphorylation site is similar for
two degenerate peptides, quantitation is achieved by summing
the peak areas of the degenerate forms. However, if the phos-
phorylation site is different in each peptide, each is considered
as an independent phosphorylation site, and quantitation can-
not be achieved by summing the peak areas.
Equation 1 was used to quantitate LPS-induced temporal
changes in the phosphorylation of three LRRFIP2 phosphopep-
tides. As shown in Fig. 3,most of the change in the abundance of
the phosphorylated forms occurred within 10 min of LPS stim-
ulation. The abundance of the SASLASLYNGGLYNPYGR
phosphopeptide increased by 2-fold, whereas the RGSGS-
DTSSLIDPDTSLSELR, SDRASPATANGGLR, and ASPA-
TANGGLR (combined is denoted as SDRASPTANGGLR) pep-
tides exhibited a 0.8–1.5-fold increase in phosphorylation over
the same time period. Fig. 3, inset 2, shows an overlay of XICs
for both the SASLASLYNGGLYNPYGR phosphopeptides (P)
and nonphosphopeptides (N) at selected time points. Similarly,
no other LRRFIP2 phosphopeptides exhibited a quantitative
phosphorylation fold-change greater than 2 (minimumof three
biological replicates over the time course). On the basis of this
observation and the fact that the majority of phosphorylation
sites showed very little to no change following LPS stimulation,
we set a 2-fold increase as the threshold for a statistically signif-
icant change in phosphorylation. It is conceivable that a quan-
titative change of less than 2-fold may also be biologically sig-
nificant in specific instances, as demonstrated previously by
quantitative mass spectrometry (12).
Cross-method Comparison of Quantitative Accuracy Pro-
vided by the AACT/SILAC-based versus Label-free Quantita-
tive Approaches—We further adapted the 3-plex AACT-based
quantitation approach (23), which was performed indepen-
dently from the label-free approaches with selected time points
to verify the accuracy of our label-free quantitation data. The
cross-method comparison/verification of site-specific phos-
phorylations identified by using multiple quantitative methods
gives additional confidence in the accuracy of our newly devel-
oped methods to screen physiologically relevant phosphoryla-
tion sites. Fig. 4 shows precursor ion pairs of the unlabeled and
Leu-d3-labeled phosphopeptides SASLASLYNGGLYNPYGR,
SDRASPATANGGLR, and ASPATANGGLR and a few non-
FIGURE 2. XIC of a doubly and triply charged peptide of M 
S200AS202LASLYNGGLYNPYGR. A–C, nonphosphopeptide. D–G, phospho-
peptide. P, phosphorylation; Na, sodiation.
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phosphopeptides of LRRFIP2.The SILAC ratio for eachpeptide
is obtained by computing the peak area ratio of the isotope
clusters between nonstimulated and LPS-stimulated condi-
tions. The raw MS spectrum of the precursor ion of the
SASLASLYNGGLYNPYGR phosphopeptide shows a signifi-
cantly higher SILAC ratio of 2.1 comparedwith other phospho-
peptides and nonphosphopeptides of LRRFP2. For example,
the corresponding average SILAC ratio of 16 leucine-contain-
ing nonphosphorylated LRRFIP2 peptides was 1.15  0.1,
whereas for nine leucine-containing phosphorylated peptides it
was 1.18  0.1 (data not shown). The SILAC ratio of the non-
phosphorylated peptides was normalized based on LRRFIP2
nonphosphopeptide ratios that remained static. The normal-
ized SILAC ratios are in close agreement with the label-free
data for most of the commonly detectable phosphopeptide
including the SASLASLYNGGLYNPYGR peptide (see supple-
mental Fig. 2S). Meanwhile, a larger number of LRRFIP2 phos-
phopeptides were quantified via label-free (11 peptides) com-
pared with (seven peptides) SILAC quantitation, suggesting
high sequence coverage of the label-free quantitation method
for analyzing the LPS-induced dynamics of multiple phospho-
peptides of an individual protein.
Discovery-based Precise Localization of Phosphorylation Sites
for Streamlined Biological Characterization—Unambiguous
assignment of phosphorylated residues in peptides with multi-
ple potential phosphorylation sites is a critical step in stream-
lining concurrent biological experiments. There are several
approaches for localizing a priori unknown phosphorylation
sites. Unambiguous localization of modifications is conven-
tionally carried out bymatching to a spectral library of standard
peptides. However, when spectra are unavailable, phosphopep-
tide synthesis is impractical for mid-to-large-scale data sets.
We performed complementary ion dissociation methods such
as CAD and ETD to obtain spectra for subsequent interpreta-
tion both manually and with automated protein database
search algorithms. Phosphosite localization software was then
used to verify the experimentally identified phosphorylation
sites. Using this novel combination of methods, we have
demonstrated the data-dependent assignment of site-specific
phosphorylation for two representative phosphopeptides,
SASLASLYNGGLYNPYGR and SDRASPTANGLLR from
LRRFIP2, in which the phosphorylation level changed 2- and
1.5-fold, respectively, 5 min after LPS stimulation.
The CAD product ion spectrum of the doubly protonated
phosphopeptide SASLASLYNGGLYNPYGR (Fig. 5A) is com-
prised of b- and y-type fragment ions resulting from peptide
backbone cleavages and a predominant neutral phosphoric acid
loss peak due to -elimination of a phosphate-containing side
chain. The loss of phosphoric acid (H3PO4) is characteristic of
both phosphoserine- and phosphothreonine-containing pep-
FIGURE 3. LPS-induced phosphorylation dynamics of selected LRRFIP2 peptides: SASLASLYNGGLYNPYGR (A), ASPATANGGLR (B), and RGSSVVSEVD-
DISIPDLSSLDEK (C). Inset 1 shows -fold changes with respect to nonstimulated t 	 0 min. Inset 2 shows the XIC of A over the selected time points, where
phosphopeptide and corresponding nonphosphopeptide peaks are shown as P and N, respectively.
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tides and can therefore be used to prescreen phosphopeptides.
However, the facile loss of phosphoric acid often leads to both
low abundance backbone fragments and fragments lacking the
phosphate moiety. Localization of a phosphorylation site in
CAD-MS/MS spectra is often challenging when several poten-
tial phosphorylation sites are present on a single peptide, as is
the case with SASLASLYNGGLYNPYGR and SDRASPTAN-
GLLR. We therefore used a neutral phosphoric acid loss MS3
experiment to identify the phosphorylation sites in these pep-
tides (see supplemental Fig. 1S). The CAD-MS/MS product ion
spectrumof the SASLASLYNGGLYNPYGRpeptide consists of
both b- and y-type ions, of which nearly all of the b-type ions
(b8  P, b13  P, b14  P, and b15  P) (See Fig. 5A) contain a
phosphate moiety, suggesting that the phosphorylation site
may be on Ser-1, Ser-3, Ser-6, or Tyr-8. The only b8 fragment
ion observed in the spectrum presumably results from H3PO4
loss, as only y8  P/y11 complementary ion pairs were
observed. The lack of a contiguous b-type ion series limits the
ability to localize the phosphorylation site using complemen-
tary y-type ions. With the exception of a single product ion
(y17  P), all of the y-type ions lacked a phosphate moiety (y5,
y6, y7, y10, y11, y12, y13, y14, y15, y16, and y17  P) (See Fig.
5A). The b8  P and y17  P ions suggest that Ser-3, Ser-6, or
Tyr-8 is phosphorylated, whereas the presence of y16 but not
y16  P suggests that Ser-1 should also be considered as a
potential phosphorylation site.
The Mascot search results shown in Table 1 list all of the
possible phosphorylation sites along with their respective ion
scores, which is helpful in localizing the correct phosphoryla-
tion site viamanual interpretation efforts. The highest ion score
is shared by potential phosphorylations on residues Ser-1 and
Ser-3. The Mascot scoring algorithm is based on all the frag-
ment ions, including fragment ions that do not contain a phos-
phate moiety. This type of scoring becomes problematic for
phosphopeptides andmay lead to ambiguous assignments with
multiple possibilities, as most phosphate-loss ions are included
in the scoring.
The y16 fragment ionmaybe a second generation neutral loss
peak and is therefore too ambiguous to assign Ser-1 as a phos-
phosite. Similarly, the y11–y15 ions may be second generation
product ions resulting from the loss of phosphoric acid. If the
assignment was based exclusively on phosphate-containing
sequence ions, the phosphorylation could be assigned to Ser-3,
Ser-6, or Tyr-8. Residues Ser-3 and Ser-6 are the most likely
candidates because of the dominant H3PO4 (98 Da) loss peak
common to phosphoserine-containing peptides. However,
phosphotyrosine-containing peptides usually produce a HPO3
(80 Da) neutral loss along with a sequential loss of H2O (18 Da),
whichmakes its neutral loss product ions analogous to aH3PO4
loss.
In addition to Mascot scoring and manual verification, we
also used the Ascore (ambiguity score) program to assist in
confidently localizing the site of phosphorylation (31). The
Ascore algorithm is a probabilistic method for assigning phos-
phorylation sites within a given phosphopeptide. The program
uses Sequest search results and spectral data as inputs to detect
phosphospecific fragment ions. The Ascore values obtained for
the SASLASLYNGGLYNPYGR peptide are shown in Table 1
FIGURE 4. AACT/SILAC-based quantitation of LRRFIP2 phosphopeptides ASPTANSGLLR, SDRASPTANSGLLR, and SASLASLYNGGLYNPYGR and
LRRFIP2 protein ratios of selected nonphosphopeptides with the measured and normalized peptide ratios.
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and were used to determine the confidence associated with
assigning a particular residue as the site of phosphorylation.
Residue Ser-3 (LRRFIP2 residue Ser-202) had the highest score
(
90% confidence) followed by Ser-6 (LRRFIP2 residue Ser-
205) and Tyr-8 (LRRFIP2 residue Tyr-207) with 80% confi-
dence. The Ascore values do not unambiguously localize the
phosphorylation site within the SASLASLYNGGLYNPYGR
peptide based on CAD data. The ambiguity associated with
localizing phosphorylation sites using Ascore is due to the
absence of phosphate-containing sequence ions that can distin-
guish each site. Incorrect assignment due to either a gas phase
rearrangement of the phosphate group or the presence of iso-
mers necessitates further analysis when multiple potential
phosphorylation sites are present on a peptide. Therefore, we
used motif-x to predict possible phosphorylation motifs on
LRRFIP2 peptides along with the program Scansite to identify
the residue-specific kinases involved in the phosphorylation
(31). Data from these analyses narrowed the potential targets of
phosphorylation to residues Ser-3 and Ser-6.
Further, to distinguish those “artificial” phosphorylations
that could occur in gas phase under nonphysiological condi-
tions, we also looked at the propensity for the same peptide
FIGURE 5. Product ion spectra resulting from CAD-MS/MS of doubly protonated phosphopeptides SASLASLYNGGLYNPYGR (A) and SDRASPATANG-
GLR (B).
TABLE 1
Identification and localization of LRRFIP2 phosphorylation sites
Mascot ion scores are significant for identity threshold 
 32 and homology threshold 
 22. Ascore 
 19 (p 	 0.01); 19 
 Ascore 
 15 (p 	 0.1) and 15 
 Ascore 
 5 (p 
0.8). Proton mobility: mobile proton peptides, number of protons 




(Mascot % confidence) Ascore
Phospho-site (Ascore
% confidence) Proton mobility for Z  2
SASLASLYNGGLYNPYGPR 200–218 88 (99) Ser-200 Mobile
88 (99) 16 Ser-202 (
90)
59 (99) 11.01 Ser-205 (80)
35 (95) 4.35 Tyr-207
RGSGDTSSLIDPDTSLSELR 326–345 112 (99) 61.52 Ser-328 (
99) Non-mobile
ASPTANSGLLR 186–199 48.59 Ser-190 (
99) Mobile
SDRASPTANSGLLR 189–199 48 (99) 28.76 Ser-190 (
99) Non-mobile
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sequence to undergo phosphate group transfer reactions
under various charge state and protonation conditions (see
supplemental Fig. 3S). The SASLASLYNGGLYNPYGR pep-
tide satisfies the conditions for having mobile protons; that
is, the number of protons on the peptide is greater than the
number of arginine residues (33). It is therefore less likely
that a phosphate group transfer would occur in this peptide
during CAD. However, when the same peptide having a
sodium ion substituted for a proton was subjected to CAD-
MS/MS, the product ions were significantly different than
those of the fully protonated analog. The most dominant
fragment ion was a neutral H3PO4 loss, which is typically
observed in peptides that have non-mobile protons. Manual
analysis of the product ions identified Ser-1 as the phosphor-
ylation site, presumably because of rearrangement of the
phosphate group. To confirm this prediction, we subjected a
doubly protonated SASLASLYNGGLYNPYGR peptide to
ETD-MS/MS. The ETD technique preserves labile post-
translational modifications such as phosphorylation while
cleaving peptide N–C bonds to yield c- and z-type frag-
ment ions. Fig. 6A shows the ETD-MS/MS product ion spec-
trum resulting from the ion/ion reaction of the doubly pro-
tonated SASLASLYNGGLYNPYGR peptide. A contiguous
z-type product ion series (z6–z17  P) along with a single
c-type product ion (c18  P) was observed. The charge-re-
duced and undissociated singly charged product ions were
not within the detectable m/z and therefore were not
observed. The almost exclusive presence of z-type ions was
expected due to the retention of charge on the arginine res-
idue. The z17  P and z16 product ions allowed us to confi-
dently assign Ser-3 (LRRFIP2 residue Ser-202) as the single
phosphorylation site on SASLASLYNGGLYNPYGR.
FIGURE 6. Product ion spectra resulting from ETD-MS/MS of protonated phosphopeptides SASLASLYNGGLYNPYGR (A) and SDRASPATANGGLR (B).
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Fig. 5B shows the CAD product ion spectrum of the
SDRASPTANGLLR peptide, which consists of the contiguous
series b5  P  b13  P and y11  P  y10  P. Based on this
spectrum, the phosphorylation site was unambiguously local-
ized to Ser-5. In addition, CID fragmentation of the ASPTAN-
GLLRpeptide also confidently localized the phosphate group to
Ser-5 (LRRFIP2 residue Ser-190). The Ascore for both the
ASPTANSGLLR and SDRASPTANSGLLR peptides indicated
that the phosphorylation site was on Ser-2 and Ser-5, respec-
tively (both corresponding to LRRFIP2 residue Ser-190), with

99% confidence.
An ETD-MS/MS spectrum of the triply protonated
SDRASPTANSGLLR peptide (shown in Fig. 6B) was also
obtained to localize the phosphorylation site(s). The presence
of a contiguous series of phosphate containing c-type ions
(c6  P  c13  P) along with their corresponding comple-
mentary z-type ions (z1–z8) suggests that the phosphorylation
sitemay be either Ser-1 or Ser-5. The contiguous series of phos-
phate containing z-type ion series (z10  P  z13  P) with
complementary c-type ions (c3 and c4) suggests that the site of
phosphorylation is Ser-5, Thr-7, or Ser-10. However, when
both c- and z-type phosphate-containing product ions are con-
sidered, the phosphorylation site could be unambiguously
localized to within two residues of Ser-5 (serine 190 at
LRRFIP2). The lack of N-terminal proline cleavage during ETD
fragmentation complemented by a dominant N-terminal pro-
line cleavage during CAD fragmentation localizes the site of
phosphorylation to within a single residue of Ser-5.
Characterization of the Functional Role of LPS-inducible
Phosphorylation in TLR4 Signaling—The biological character-
ization experiments were performed on identified phosphory-
lation sites showing LPS-inducible changes either greater than
or less than the 2-fold threshold. These experiments provide a
means of evaluating the biological accuracy of LPS-induced
site-specific phosphorylation changes determined by label-free
quantitation and also illustrate the biological significance/rele-
vance of our quantitative threshold. Specifically, we explored
the possible impact of certain newly identified phosphorylation
sites on the LPS-induced interaction between LRRFIP2 and
MyD88, which in turn may affect downstream NF-B activity.
We have focused on three serine residues, Ser-190, Ser-200,
and Ser-202, which represent three different categories of the
phosphorylation quantified and identified by our label-free
approach. Ser-190 showed a 1.5-fold increase in its phosphory-
lated form in early cellular response to LPS (Fig. 3), whereas
an LPS-induced 2.0-fold increase in phosphorylation was
observed for the peptide consisting of Ser-200 and Ser-202. The
unambiguous identification of phosphorylation at Ser-202 and
the false-positive identification of phosphorylation at Ser-200
due to a gas phase relocation of the phosphate group (supple-
mental Fig. 3S) therefore suggested that the 2-fold change was
solely attributable to Ser-202, whereas Ser-200 remained com-
pletely devoid of phosphorylation, at least under these condi-
tions. We could therefore assign Ser-200 as a negative control
for all biological experiments, whereas the Ser-190 and Ser-202
sites having different phosphorylation fold changes were eval-
uated for their biological activity.
Through site-directed mutagenesis, we substituted each of
the serine residues at positions 190, 200, and 202 or their com-
bination with alanine or glutamic acid to make the phosphory-
lation-depleted single or double mutants. These mutants
include S202A, S202E, S200A, S190A, and S202A,S190A,
respectively. Conversely, the S202Emutant wasmade tomimic
the charge state of the phosphorylated LRRFIP2 at Ser-202.
First, the effect of site-specific phosphorylation or “lack
thereof” on LPS-induced signal transduction was assessed by
comparing both differences in NF-B activity associated with
human wild-type LRRFIP2 versus the corresponding mutants.
By using shRNA (12) we first knocked down the endogenous
mouse LRRFIP2 in RAW cells and then transfected RAW cells
with the human version of either wild-type LRRFIP2 or each of
these mutants by using a relatively efficient jetPRIME transfec-
tion kit. Fig. 7A shows that we achieved a 60% knockdown of
endogenous mouse LRRFIP2 compared with scrambled
shRNA. Because of the low abundance of LRRFIP2 in total cell
lysates, the expression of each exogenous human LRRFIP2 or
its mutant transfected into RAW cells was measured by immu-
noblotting following an enrichment step of immunoprecipita-
tion on the equal amount of each transfected cells with equal
amount of anti-FLAG beads (Fig. 7B). LPS-induced NF-B
activity was then determined via a luciferase reporter assay on
the RAWmacrophage cells transfectedwith the human version
of either wild-type LRRFIP2 or each of these mutants, respec-
tively. As a result, although the mutants, S190A, S200A, and
S202E, did not show any measurable change in NF-B activity
compared with the wild-type LRRFIP2, we found that the abol-
ishment of the phosphorylation propensity at Ser-202 (i.e.
S202A) led to a 44% reduction of LPS-induced NF-B activity
(Fig. 7C). Similar to the S202Amutant, the macrophages trans-
fected with the double mutant S202A,S190A showed a 43%
reduction in NF-B activity, implying that the reduction in
NF-B activation is primarily attributable to the depletion of
serine at position 202, and the loss of phosphate at serine 190
has little effect on NF-B activity. We also comparatively mea-
sured the changes in NF-B activity caused by the direct trans-
fection of either the wild type or each LRRFIP2 mutant to the
RAW cells without pre-LRRFIP2 knockdown by shRNA. An
approximate 20% reduction in NF-B activity was observed
(supplemental Fig. 4S), indicating that the actual effect of the
phosphoserine at 202 on NF-B activity is undermined by
endogenous wild-type LRRFIP2. Considering that the endoge-
nous wild-type LRRFIP2 residual in RAW cells may contribute
to the overall LPS-induced NF-B activity, the actual effect of
the LPS-inducible phosphorylation at Ser-202 on NF-B activ-
ity in the cells with a complete wild-type “knock-out” should be
more than the observed 44% reduction.
Further, because of the regulatory role of dynamic MyD88-
LRRFIP2 interaction in modulating downstream LPS-induced
NF-B activity, we comparatively examined the LPS-induced
and time course-dependent binding between MyD88 and
either wild-type LRRFIP2 or the S202A or S202E LRRFIP2
mutant, respectively, across the full course of LPS-induced
TLR4 signaling. We transiently co-transfected HA-tagged
MyD88 with FLAG-tagged LRRFIP2 or the S202A or S202E
mutant, respectively, along with MD2 to the HEK293T cells
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stably expressing TLR4 and then stimulated these cells with
LPS. The LPS-stimulated cells were collected, respectively, at
different time points (0, 5, 10, 15, 20, 30, 60, and 120 min), and
theMyD88-interacting complexwas pulled down using theHA
tag. The population of the MyD88-associating LRRFIP2 or its
mutants was detected by immunoblotting using anti-FLAG
antibody. In the immunoprecipitate isolated from unstimu-
lated resting cells, two bands in doublet were observed for the
MyD88-LRRFIP2 association at a basal level (Fig. 8, top panel).
In the complexes pulled down from the stimulated cells follow-
ing LPS stimulation for 5–15 min, the intensity of this doublet
indicative of the binding strength between MyD88 and wild-
type LRRFIP2 was significantly enhanced along with a newly
appearing slow-migrating species. A longer LPS stimulation for
20–30 min resulted in decreased binding between LRRFIP2
andMyD88, implicating possible dissociation of LRRFIP2 from
FIGURE 7. A, close to 60% knockdown of endogenous mouse LRRFIP2 was found in RAW264.7 cells using shRNA. Scrambled shRNA was used as a negative
control. B, expression of human LRRFIP2 constructs in the endogenous mouse LRRFIP2 knockdown background in RAW264.7 cells. Cells were transfected with
each construct and lysed, and the protein was immunoprecipitated using the FLAG tag. EV, empty vector. C, NF-B activity of the human LRRFIP2 mutants in
RAW264.7 cells in the background of mouse LRRFIP2 knockdown.
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the MyD88 complex. LPS stimulation for 60–120 min resulted
in a slight increase in their interaction; however, it was compar-
atively less than the interaction during the onset between 5–15
min of LPS-induced interactions. Furthermore, after 20 min of
LPS stimulation, the migration pattern associated with the
increased levels of phosphorylated LRRFIP2 reverted back to
the doublet pattern observed for unstimulated cells. Overall,
these LPS-induced changes in the MyD88-LRRFIP2 binding
pattern closely correlate with the dynamic changes in LRRFIP2
phosphorylation, as evidenced by our label-free quantitative
mass spectrometry results (Fig. 3). In contrast, MyD88 binding
to the LRRFIP2 S202Amutant showed only two species, which
were apparently not LPS-inducible and remained little changed
through the full course following LPS stimulation (Fig. 8,mid-
dle panel). Further, in the binding ofMyD88 to LRRFIP2 S202E,
the slow-migrating species, which appeared only after 5 min of
LPS stimulation in the cells transfectedwithwild-type LRRFIP2
(Fig. 8, top panel), was observed under the unstimulated state
(Fig. 8, bottom panel), implying that the slow-migrating species
mimicked by a glutamic acid corresponds to the LPS-induced
phosphorylation of LRRFIP2 at Ser-202. Further, although this
binding pattern was shown to differ from that of MyD88 with
wild-type LRRFIP2, the interaction between MyD88 and the
LRRFIP2 S202Emutant is clearly LPS-inducible with enhanced
binding during the first 20 min. All of these observations firmly
indicated that the addition of a net negative charge to LRRFIP2
by either phosphate group or phosphomimetic glutamic acid is
essential for the signal-promoting interaction between MyD88
and LRRFIP2. In correlationwith themutation effect onNF-B
activity, our results collectively indicated that site-specific
phosphorylation at LRRFIP2 is indeed involved in regulating
the interaction between LRRFIP2 and MyD88 to modulate the
dynamics of NF-B regulation upon LPS stimulation.
Here, our study provides clear evidence of how an LPS-in-
ducible dynamic and site-specific phosphorylation at the signal
protein, LRRFIP2, could regulate its temporal interaction with
the critical TLR adaptor proteinMyD88, which controls TLR4-
mediated cellular signaling in a timely and orderly manner.
Using our targetedMS-based label-free quantitation approach,
both precise quantitation and unambiguous identification can
be achieved for site-specific phosphorylation, with clear impli-
cations for their possible functional role in signal transduction.
This multiplex quantitation methodology uses both phospho-
peptide and nonphosphopeptide counterparts for relative
quantitation across various time points during the full course of
the cellular response to LPS stimulation. To our knowledge,
this is the first attempt to measure simultaneous changes in
multiple phosphorylation sites of a newly characterized signal-
ing protein. The method discerns differential phosphorylation
to overall change in protein expression as reported previously
for SILAC-based quantitation (43). Although phosphopeptide
abundances are not reflective of the absolute levels of phos-
phorylation, most phosphorylation sites, including phospho-
peptide consisting of Ser-202, show high levels of basal phos-
phorylation, suggesting that an increase in phosphorylation
as a result of LPS stimulation becomes biologically signifi-
cant and can regulate specific protein interactions. The
SAS202LASLYNGGLYNPYGR peptide shows a 2-fold increase
in phosphorylation from both the label-free and AACT-based
quantitation methods, suggesting that phosphorylation at Ser-
202 is LPS-inducible. The mass spectrometry data were vali-
dated by both binding and NF-B activity assays. In nonstimu-
lated cells, LRRFIP2 is associatedwith theMyD88 complex that
was found at a basal level in both the wild type and the S202A
mutant. The LPS-induced, time course-dependent dynamics of
the LRRFIP2-MyD88 interaction is closely correlated with that
of site-specific phosphorylation(s) of LRRFIP2 determined by
label-free quantitation. Correspondingly, the mutations of
LRRFIP2 led to the loss of these LPS-induced dynamics, sug-
gesting the unresponsive status of themacrophages to LPS. The
phosphorylation of Ser-202 at LRRFIP2 apparently regulates
the temporal interactions between LRRFIP2 and MyD88 that
modulate the LPS-induced TLR4-mediated cellular response
(12).
Strategically, we have demonstrated how a discovery-
based mass spectrometry strategy with high precision can be
utilized to characterize a novel role of site-specific phosphor-
ylation and its dynamic interplay with specific protein-pro-
tein interactions for regulating signal transduction as well as
for signal control. The accurate identification and quantifi-
cation of site-specific phosphorylation, in this study, pro-
vided critical insights for guiding the concurrent biological
characterization. These concerted discovery and biological
characterization experiments implicate site-specific phos-
phorylation of LRRFIP2 as playing a pivotal role in modulat-
ing TLR4-mediated signaling.
FIGURE 8. Changes in the interaction between wild-type LRRFIP2 and
MyD88 upon LPS stimulation. Cells were transfected for transient expres-
sion of wild-type FLAG-LRRFIP2 or its mutant S202A or S202E, HA-MyD88, and
MD2 as described under “Experimental Procedures.” Mock control was not
transfected with plasmid DNA. Cells were then stimulated with or without LPS
at 1 g/ml for various amounts of time as indicated. Cells were lysed, and the
MyD88-interacting complex was immunoprecipitated. Whole-cell lysates
(WCL) and immunoprecipitates (IP) were analyzed by Immunoblotting (IB) for
FLAG-LRRFIP2 and HA-MyD88.
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